Artcline

Artcline GmbH is a leading biotechnology company in the field of extracorporeal sepsis treatment based on immune cells, dedicated to advancing novel immune cell-based extracorporeal sepsis therapies. The ARTICE® therapy utilizes immune cells from healthy blood donors to temporarily take over certain functions and re-activate the patient's own immune system.